Multifunctional Fe3O4 mesocrystals for cancer therapy: integrating hyperthermia and targeted drug delivery

Abstract

Mesocrystals with hierarchical architecture and crystallographically aligned nanoparticles hold immense potential for advanced applications in catalysis, energy storage and biomedicine. However, challenges arise for biomedical applications due to their surfactant-controlled growth, lack of understanding of magnetic mesocrystals and their dopant effect. Herein, we report a facile, additive-free solvothermal synthesis of Fe3O4 mesocrystals (∼205 nm) and investigate their morphological evolution by correlating the structural changes with respect to magnetic properties. The Fe3O4 mesocrystals exhibit a high saturation magnetization of 87 emu g−1, surpassing that of conventional nanoparticles (55.29 emu g−1) suitable for magnetic hyperthermia. A therapeutic temperature of 42 °C was reached at 5 and 10 mg mL−1 under applied fields of 20 and 26.7 kA m−1 in water and 2% agar media within the clinical safety limit. Furthermore, they exhibit an excellent drug encapsulation efficiency of 41.09% for paclitaxel (PTX) drugs, significantly outperforming that of the nanoparticles (19.4%), which is attributed to the internal voids of mesocrystals, nanoparticle building units and hierarchical structures with release profiles of 28% and 41% at pH 7.4 and 5.5, respectively. In vitro studies reveal 82% biocompatibility with L-929 fibroblast cells and 60% cell viability against HCT 116 colon cancer cells at 1 mg mL−1. At this concentration, Fe3O4 mesocrystals embedded with PTX show a 95% reduction in cancer cell viability. We also probed the structural characteristics using XRD, Raman, FT-IR, SEM, TEM and XPS analyses. By integrating magnetic hyperthermia with pH-dependent drug release, this work establishes Fe3O4 mesocrystals as a dual-functional platform for targeted cancer therapy, offering a transformative approach to overcome the limitations in nanomedicine.

Graphical abstract: Multifunctional Fe3O4 mesocrystals for cancer therapy: integrating hyperthermia and targeted drug delivery

Supplementary files

Article information

Article type
Paper
Submitted
07 Feb 2025
Accepted
30 Jul 2025
First published
01 Aug 2025

J. Mater. Chem. B, 2025, Advance Article

Multifunctional Fe3O4 mesocrystals for cancer therapy: integrating hyperthermia and targeted drug delivery

A. Marsalin, N. Saravanan, A. Sundaramurthy, S. S. Phalake, V. M. Khot and R. Mani, J. Mater. Chem. B, 2025, Advance Article , DOI: 10.1039/D5TB00282F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements